Trade Summary

1 week ago, Mottola Frank, serving as SVP, Chief Tech. Ops. Officer at Supernus Pharmaceuticals, Inc. (SUPN), sold 20,000 shares at $50.41 per share, for a total transaction value of $1,008,150.00. Following this transaction, Mottola Frank now holds 15,496 shares of SUPN.

This sale represents a 56.00% decrease in Mottola Frank's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, December 19, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 22, 2025, 3 days after the trade was made.